Elanco Animal Health
ELAN
388 hedge funds and large institutions have $7.08B invested in Elanco Animal Health in 2024 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 160 increasing their positions, 120 reducing their positions, and 62 closing their positions.
405% more call options, than puts
Call options by funds: $81.4M | Put options by funds: $16.1M
133% more funds holding in top 10
Funds holding in top 10: 3 → 7 (+4)
33% more repeat investments, than reductions
Existing positions increased: 160 | Existing positions reduced: 120
2% more capital invested
Capital invested by funds: $6.96B → $7.08B (+$114M)
0.14% less ownership
Funds ownership: 97.61% → 97.47% (-0.14%)
3% less funds holding
Funds holding: 402 → 388 (-14)
19% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 62
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$157M |
| 2 |
JP Morgan Chase
New York
|
+$60.8M |
| 3 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
+$47.2M |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$31.2M |
| 5 |
SCM
Shapiro Capital Management
Atlanta,
Georgia
|
+$27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$349M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$73.6M |
| 3 |
Holocene Advisors
New York
|
-$40.4M |
| 4 |
D.E. Shaw & Co
New York
|
-$20.9M |
| 5 |
Goldman Sachs
New York
|
-$19.6M |
ELAN Hedge Fund Activity: Q3 2024 in Review
388 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q3 2024, worth a combined $7.08B — up 1.6% from $6.96B a quarter earlier.
Sellers outnumbered buyers: 62 funds closed out of ELAN and 50 opened new positions — a net loss of 12 holders — while 120 trimmed existing stakes and 160 added.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $157M. The largest seller was T. Rowe Price Associates, cutting an estimated $349M.
- 388 institutional investors held Elanco Animal Health (ELAN) as of Q3 2024, down from 402 in Q2 2024.
- Funds reported $7.08B of Elanco Animal Health stock for Q3 2024, up 1.6% quarter-over-quarter.
- 50 funds opened new Elanco Animal Health positions in Q3 2024 and 62 closed out, a net change of -12 holders.
- The largest Elanco Animal Health buyer in Q3 2024 was T. Rowe Price Investment Management, an estimated $157M added.
- The largest Elanco Animal Health seller in Q3 2024 was T. Rowe Price Associates, an estimated $349M sold.
Based on aggregated 13F filings for Q3 2024.